The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Hematopoietic recovery and immune reconstitution after axi-cel CAR T-cell therapy in patients with relapsed/refractory large B-cell lymphoma.
 
Paolo Strati
No Relationships to Disclose
 
Sherry Adkins
No Relationships to Disclose
 
Loretta J. Nastoupil
Honoraria - Bayer; Celgene; Gilead Sciences; Janssen Oncology; Novartis; Spectrum Pharmaceuticals
Research Funding - Celgene; Genentech/Roche; Janssen Biotech; Karus Therapeutics; LAM Therapeutics; TG Therapeutics
 
Jason Westin
Consulting or Advisory Role - Celgene; Genentech/Abbvie; Kite, a Gilead company; Kite/Gilead; Novartis; ProNAi; Spectrum Pharmaceuticals
Research Funding - Bristol-Myers Squibb; Celgene; Genentech; Janssen; Karyopharm Therapeutics; Kite/Gilead; Novartis; ProNAi
 
Fredrick B. Hagemeister
No Relationships to Disclose
 
Nathan Hale Fowler
Consulting or Advisory Role - Bayer; Celgene; Novartis; Roche/Genentech; TG Therapeutics; Verastem
Research Funding - Abbvie; BeiGene; Celgene; Gilead Sciences; Novartis; Roche; TG Therapeutics
 
Hun Ju Lee
No Relationships to Disclose
 
Luis Fayad
No Relationships to Disclose
 
Felipe Samaniego
No Relationships to Disclose
 
Sairah Ahmed
No Relationships to Disclose
 
Ankur Varma
No Relationships to Disclose
 
Sara Arafat
No Relationships to Disclose
 
Swapna Johncy
No Relationships to Disclose
 
Partow Kebriaei
No Relationships to Disclose
 
Victor Mulanovich
No Relationships to Disclose
 
Ella Ariza-Heredia
No Relationships to Disclose
 
Sattva Swarup Neelapu
Honoraria - Bio Ascend; Dava Oncology; Medscape; Physicans' Education Resource
Consulting or Advisory Role - Celgene; Cell Medica; Gilead Sciences; Incyte; Kite, a Gilead company; Merck Sharp & Dohme; Novartis; Pfizer; Precision Biosciences; Unum Therapeutics
Research Funding - Acerta Pharma; Bristol-Myers Squibb; Celgene; Cellectis; Gilead Sciences; Karus Therapeutics; Kite, a Gilead company; Merck Sharp & Dohme; Pharmacyclics; poseida therapeutics; Unum Therapeutics
Travel, Accommodations, Expenses - Celgene; Chugai Pharma; Dava Oncology; Kite/Gilead; Medscape; Merck; Novartis; Pfizer; Physicans' Education Resource; Precision Biosciences; Unum Therapeutics